Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 7.8% | 596,433 | 0 | 596,433 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 7.8% | 596,433 | 0 | 596,433 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.3% | 165,382 | 0 | 165,382 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.3% | 165,382 | 0 | 165,382 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.9% | 761,815 | 0 | 761,815 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 768,200 | 0 | 768,200 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 768,200 | 0 | 768,200 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 768,200 | 0 | 768,200 | /s/ Mark N. Lampert | Mark N. Lampert |